Page 399 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 399
OWL Metabolomics 420 L
Edif. 502, Parque Tecnologico de Bizkaia
48160, Derio
Spain
www.owlmetabolomics.com
OWL is a biotechnology company in the field of Metabolomics with pioneering diagnostics
products and unique R&D services for the scientific community. OWL´s two business lines
stem from our in depth knowledge of metabolomics and liver diseases. DIAGNOSTIC
PRODUCTS: "OWLiverTest" is the first "in vitro" test for determining steatosis and NASH.
The company also develops diagnostic markers research for high prevalence diseases. R&D
SERVICES: OWL applies its expertise in metabolomics and lipidomics to provide services
to the pharmaceutical, food and cosmetics industries, as well as research centers, biotech
companies and CROs.
Perspectum Diagnostics Ltd 440 M
New Road
Oxford, OX11BY
The United Kingdom
www.perspectum-diagnostics.com
Perspectum Diagnostics has been founded by physicians, scientists, and engineers with
patented technology and know-how to develop solutions for major unmet needs in
diagnostic medicine. Perspectum's first product, LiverMultiScan offers a non-invasive
accurate assessment method that can help doctors achieve a diagnosis by providing detailed
information on tissue characteristics as well as architectural changes, thereby enabling a
much more rapid and accurate diagnosis of liver disease than is possible with current blood
and ultrasound tests.
PHILIPS 440 D INDUSTRY INFORMATION
525, VB-4 Boschdijk
5600 JJ, Eindhoven
The Netherlands
www.philips.com/healthcare
Creating a healthier future, together
At Philips, we look beyond technology to the experiences of patients, providers and caregivers
across the health continuum from healthy living to prevention, diagnosis, treatment,
recovery and home care.We unlock insights leading to meaningful innovations from hospital
to home. Our solutions combine clinical breadth and depth of expertise, technology and
services, actionable data, consultative new business models and partnerships. Together,
with our customers, we take risks and share responsibility – so that we can transform how
care is delivered and experienced. It’s a unique perspective empowering us all to create a
healthier future.
Vienna, Austria • April 22–26, 2015 399
Edif. 502, Parque Tecnologico de Bizkaia
48160, Derio
Spain
www.owlmetabolomics.com
OWL is a biotechnology company in the field of Metabolomics with pioneering diagnostics
products and unique R&D services for the scientific community. OWL´s two business lines
stem from our in depth knowledge of metabolomics and liver diseases. DIAGNOSTIC
PRODUCTS: "OWLiverTest" is the first "in vitro" test for determining steatosis and NASH.
The company also develops diagnostic markers research for high prevalence diseases. R&D
SERVICES: OWL applies its expertise in metabolomics and lipidomics to provide services
to the pharmaceutical, food and cosmetics industries, as well as research centers, biotech
companies and CROs.
Perspectum Diagnostics Ltd 440 M
New Road
Oxford, OX11BY
The United Kingdom
www.perspectum-diagnostics.com
Perspectum Diagnostics has been founded by physicians, scientists, and engineers with
patented technology and know-how to develop solutions for major unmet needs in
diagnostic medicine. Perspectum's first product, LiverMultiScan offers a non-invasive
accurate assessment method that can help doctors achieve a diagnosis by providing detailed
information on tissue characteristics as well as architectural changes, thereby enabling a
much more rapid and accurate diagnosis of liver disease than is possible with current blood
and ultrasound tests.
PHILIPS 440 D INDUSTRY INFORMATION
525, VB-4 Boschdijk
5600 JJ, Eindhoven
The Netherlands
www.philips.com/healthcare
Creating a healthier future, together
At Philips, we look beyond technology to the experiences of patients, providers and caregivers
across the health continuum from healthy living to prevention, diagnosis, treatment,
recovery and home care.We unlock insights leading to meaningful innovations from hospital
to home. Our solutions combine clinical breadth and depth of expertise, technology and
services, actionable data, consultative new business models and partnerships. Together,
with our customers, we take risks and share responsibility – so that we can transform how
care is delivered and experienced. It’s a unique perspective empowering us all to create a
healthier future.
Vienna, Austria • April 22–26, 2015 399
